Displaying One Session

View
Vienna Hall Controversy session

Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)

Date
04.05.2019
Time
08:30 - 09:30
Location
Vienna Hall
Chairs
  • Fabrice André (Villejuif, France)
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22) Controversy session

Introduction and first vote (ID 58)

Lecture Time
08:30 - 08:40
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:30 - 09:30
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22) Controversy session

Pro (ID 59)

Lecture Time
08:40 - 09:00
Speakers
  • Jonas Bergh (Solna, Solna, Sweden)
Session Name
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:30 - 09:30
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22) Controversy session

Contra (ID 60)

Lecture Time
09:00 - 09:20
Speakers
  • Valentina Guarneri (Padova, Italy)
Session Name
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:30 - 09:30
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22) Controversy session

Second vote and conclusions (ID 62)

Lecture Time
09:20 - 09:30
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:30 - 09:30